# Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia

> **NCT02286284** · PHASE2 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 2 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **DEVICE:** Apheresis for extracorporal removal of sFlt-1

## Key facts

- **NCT ID:** NCT02286284
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Safety of patients : CSI recommandation and promotor decision
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02286284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02286284, "Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02286284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*